{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:04:32Z","timestamp":1790006672431,"version":"4.0.1"},"reference-count":28,"publisher":"Mattioli1885","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background: Isotretinoin is a systemic retinoid widely used for the treatment of severe acne vulgaris. While its dermatologic side effects are well known, its potential impact on periodontal health has not been fully elucidated. Objective: This prospective study aimed to evaluate the effects of systemic isotretinoin therapy on clinical periodontal parameters in young adults treated for acne vulgaris. Methods: A total of 80 patients (59 females and 21 males), aged between 18 and 25 years, undergoing systemic isotretinoin therapy (0.5\u202fmg\/kg\/day for months 0\u20133 and 0.7\u202fmg\/kg\/day for months 4\u20136) for a duration of six months, were included in the study. Clinical periodontal assessments, including bleeding on probing (BOP), plaque index (PI), and probing depth (PD), were performed at baseline and after six months. Patients with systemic conditions, recent dental treatments or antibiotic use, and other potential confounding factors were excluded. Data were analyzed using the Wilcoxon signed-rank test, McNemar test, and regression analysis. Results: Posttreatment assessments showed a significant increase in the prevalence of BOP (from 18.8% to 48.8%, P&lt;0.001). The mean PI increased from 1.06\u202f\u00b1\u202f1.24 to 1.26\u202f\u00b1\u202f1.25 (P=0.007), while the mean PD rose from 1.25\u202f\u00b1\u202f1.06 mm to 1.73\u202f\u00b1\u202f1.08 mm (P&lt;0.001). No significant association was found between changes in periodontal parameters and age or sex, as determined by regression analysis. Conclusion: Isotretinoin therapy may contribute to subclinical deterioration in periodontal health, as evidenced by increased BOP, PI, and PD values. Although these changes were modest, clinicians prescribing isotretinoin should consider potential oral health implications and advise patients accordingly. For dermatologists, incorporating basic periodontal screening into routine care may help identify at-risk patients early.<\/jats:p>","DOI":"10.5826\/dpc.1602a6739","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:48:33Z","timestamp":1777571313000},"page":"6739","source":"Crossref","is-referenced-by-count":1,"title":["Isotretinoin Beyond the Skin: A Prospective Study on Its Impact on Periodontal Health"],"prefix":"10.5826","volume":"16","author":[{"given":"Funda","family":"Erduran","sequence":"first","affiliation":[{"name":"Ankara Bilkent City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Do\u011fuhan","family":"\u00c7o\u015flu","sequence":"first","affiliation":[{"name":"Ankara Bilkent City Hospital, Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Karaaslan","sequence":"first","affiliation":[{"name":"Ankara Bilkent City Hospital, Department of Oral and Dental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Emre","sequence":"first","affiliation":[{"name":"Ufuk University, Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27750","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"10.5826\/dpc.1602a6739_ref1","doi-asserted-by":"crossref","unstructured":"Van Steensel MAM. The genetics of acne. Ann Hum Genet. 2025 Jul 21. DOI: 10.1111\/ahg.70014","DOI":"10.1111\/ahg.70014"},{"key":"10.5826\/dpc.1602a6739_ref2","doi-asserted-by":"crossref","unstructured":"Saurat JH, Halioua B, Baissac C, et al. Epidemiology of acne and rosacea: A worldwide global study. J Am Acad Dermatol. 2024 May;90(5):1016-1018. DOI: 10.1016\/j.jaad.2023.12.038","DOI":"10.1016\/j.jaad.2023.12.038"},{"key":"10.5826\/dpc.1602a6739_ref3","doi-asserted-by":"crossref","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019 Jul;311(5):337-349. DOI: 10.1007\/s00403-019-01908-x","DOI":"10.1007\/s00403-019-01908-x"},{"key":"10.5826\/dpc.1602a6739_ref4","doi-asserted-by":"crossref","unstructured":"Bagatin E, Costa CS. The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020 Aug;13(8):885-897. DOI: 10.1080\/17512433.2020.1796637","DOI":"10.1080\/17512433.2020.1796637"},{"key":"10.5826\/dpc.1602a6739_ref5","doi-asserted-by":"crossref","unstructured":"Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. 2022 Sep;35(9):e15719. DOI: 10.1111\/dth.15719","DOI":"10.1111\/dth.15719"},{"key":"10.5826\/dpc.1602a6739_ref6","doi-asserted-by":"crossref","unstructured":"Paichitrojjana A, Paichitrojjana A. Oral Isotretinoin and Its Uses in Dermatology: A Review. Drug Des Devel Ther. 2023 Aug 25;17:2573-2591. DOI: 10.2147\/DDDT.S427530","DOI":"10.2147\/DDDT.S427530"},{"key":"10.5826\/dpc.1602a6739_ref7","doi-asserted-by":"crossref","unstructured":"Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, Roohaninasab M, Najar Nobari N, Behrangi E. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021 Jan;34(1):e14438. DOI: 10.1111\/dth.14438","DOI":"10.1111\/dth.14438"},{"key":"10.5826\/dpc.1602a6739_ref8","doi-asserted-by":"crossref","unstructured":"Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012 Sep;132(9):2198-205. DOI: 10.1038\/jid.2012.111","DOI":"10.1038\/jid.2012.111"},{"key":"10.5826\/dpc.1602a6739_ref9","doi-asserted-by":"crossref","unstructured":"Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2229-2240. DOI: 10.1111\/jdv.16430","DOI":"10.1111\/jdv.16430"},{"key":"10.5826\/dpc.1602a6739_ref10","doi-asserted-by":"crossref","unstructured":"Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008 Sep;27(3):197-206. DOI: 10.1016\/j.sder.2008.07.002","DOI":"10.1016\/j.sder.2008.07.002"},{"key":"10.5826\/dpc.1602a6739_ref11","doi-asserted-by":"crossref","unstructured":"Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017 Jul;30(4). DOI: 10.1111\/dth.12483","DOI":"10.1111\/dth.12483"},{"key":"10.5826\/dpc.1602a6739_ref12","doi-asserted-by":"crossref","unstructured":"Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol. 123:606-608, 1987 13.","DOI":"10.1001\/archderm.1987.01660290074019"},{"key":"10.5826\/dpc.1602a6739_ref13","doi-asserted-by":"crossref","unstructured":"Exner JH, Dahod S, Pochi PE.Pyogenic granuloma-like acne lesions during isotretinoin therapy. Arch Dermatol. 1983;119:808-811.","DOI":"10.1001\/archderm.1983.01650340018012"},{"key":"10.5826\/dpc.1602a6739_ref14","doi-asserted-by":"crossref","unstructured":"Ruchitha S, Gupta N, Singh K. Exploring the multifaceted side effects of isotretinoin: a deep dive into case reports and observational studies. Arch Dermatol Res. 2025 Feb 26;317(1):499. DOI: 10.1007\/s00403-025-04019-y","DOI":"10.1007\/s00403-025-04019-y"},{"key":"10.5826\/dpc.1602a6739_ref15","doi-asserted-by":"crossref","unstructured":"Heitz-Mayfield LJA. Conventional diagnostic criteria for periodontal diseases (plaque-induced gingivitis and periodontitis). Periodontol 2000. 2024 Jun;95(1):10-19. DOI: 10.1111\/prd.12579","DOI":"10.1111\/prd.12579"},{"key":"10.5826\/dpc.1602a6739_ref16","doi-asserted-by":"crossref","unstructured":"Ito H, Numabe Y, Hashimoto S, et al. Correlation Between Gingival Crevicular Fluid Hemoglobin Content and Periodontal Clinical Parameters. J Periodontol. 2016 Nov;87(11):1314-1319. DOI: 10.1902\/jop.2016.160092","DOI":"10.1902\/jop.2016.160092"},{"key":"10.5826\/dpc.1602a6739_ref17","doi-asserted-by":"crossref","unstructured":"Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964 Feb;22:121-35. DOI: 10.3109\/00016356408993968","DOI":"10.3109\/00016356408993968"},{"key":"10.5826\/dpc.1602a6739_ref18","doi-asserted-by":"crossref","unstructured":"Loe H. The gingival index, the plaque index and the retention index Systems. J Periodonto.l 1967;38:Suppl:610-6.","DOI":"10.1902\/jop.1967.38.6.610"},{"key":"10.5826\/dpc.1602a6739_ref19","doi-asserted-by":"crossref","unstructured":"AlJasser R, AlAqeely R, AlKenani M, AlQahtani S, AlZahrani A, Lambarte R. The effect of systemic Isotretinoin on salivary tissue inhibitors of metalloproteinases 1 and 2 and salivary flow rate in periodontal disease. Saudi J Biol Sci. 2022 Jan;29(1):148-153. DOI: 10.1016\/j.sjbs.2021.08.079","DOI":"10.1016\/j.sjbs.2021.08.079"},{"key":"10.5826\/dpc.1602a6739_ref20","doi-asserted-by":"crossref","unstructured":"AlJasser RN, Alaqeely RS, Al-Hoqail IA, et al. Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels. Front Biosci (Landmark Ed). 2021 Jul 30;26(7):191-197. DOI: 10.52586\/4933","DOI":"10.52586\/4933"},{"key":"10.5826\/dpc.1602a6739_ref21","doi-asserted-by":"crossref","unstructured":"AlJasser R, AlAqeely R, AlZahrani A, et al. Antimicrobial Effect of Isotretinoin Therapy on Periodontal Pathogens: A Case-Control Study. Antibiotics (Basel). 2021 Oct 21;10(11):1286. DOI: 10.3390\/antibiotics10111286","DOI":"10.3390\/antibiotics10111286"},{"key":"10.5826\/dpc.1602a6739_ref22","doi-asserted-by":"crossref","unstructured":"Mahajan A, Bharadwaj A, Mahajan P. Non\u2010Plaque\u2010Induced Gingivitis Associated With Isotretinoin: A Case Report. Clin adv periodontics. 2011;1(3):205- 9.","DOI":"10.1902\/cap.2011.110006"},{"key":"10.5826\/dpc.1602a6739_ref23","doi-asserted-by":"crossref","unstructured":"Shibuya N, Nemoto E, Kanaya S, Kunii R, Shimauchi H. Retinoic acid is a potential negative regulator for differentiation of human periodontal ligament cells. J Periodontal Res. 2005 Dec;40(6):432-440. DOI: 10.1111\/j.1600-0765.2005.00811.x","DOI":"10.1111\/j.1600-0765.2005.00811.x"},{"key":"10.5826\/dpc.1602a6739_ref24","doi-asserted-by":"crossref","unstructured":"Ustao\u011flu G, G\u00fcler \u015e, Polat M. Effect of isotretinoin on periodontal tissues and oxidative stress markers in the saliva. Turkderm-Turk Arch Dermatol Venereol. 2020;54(4):132-137. DOI:10.4274\/turkderm.galenos.2020.99896","DOI":"10.4274\/turkderm.galenos.2020.99896"},{"key":"10.5826\/dpc.1602a6739_ref25","doi-asserted-by":"crossref","unstructured":"Yorulmaz Demir A, Metin A, I\u015f\u0131ko\u011flu S, Erel \u00d6. The effect of isotretinoin on oxidative stress in severe acne vulgaris patients. Turkiye Klinikleri J Med Sci. 2012;32:1026-1031.","DOI":"10.5336\/medsci.2011-26690"},{"key":"10.5826\/dpc.1602a6739_ref26","doi-asserted-by":"crossref","unstructured":"Lynge Pedersen AM, Belstr\u00f8m D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019 Jan;80 Suppl 1:S3-S12. DOI: 10.1016\/j.jdent.2018.08.010","DOI":"10.1016\/j.jdent.2018.08.010"},{"key":"10.5826\/dpc.1602a6739_ref27","doi-asserted-by":"crossref","unstructured":"Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996 Jul;10(9):1002-13. DOI: 10.1096\/fasebj.10.9.8801161","DOI":"10.1096\/fasebj.10.9.8801161"},{"key":"10.5826\/dpc.1602a6739_ref28","doi-asserted-by":"crossref","unstructured":"Kautsky MB, Fleckman P, Dale BA. Retinoic acid regulates oral epithelial differentiation by two mechanisms. J Invest Dermatol. 1995 Apr;104(4):546-53. DOI: 10.1111\/1523-1747.ep12606058","DOI":"10.1111\/1523-1747.ep12606058"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/download\/6739\/3866","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/download\/6739\/3866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:47:34Z","timestamp":1778687254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/view\/6739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1602a6739","relation":{"has-manifestation":[{"id-type":"other","id":"1-83-6739-g3866","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1602a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"value":"2160-9381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"9"}}